A randomized clinical trial from researchers at the University of Pittsburgh suggests that targeted theta burst stimulation may strengthen placebo-related mood improvements by changing activity inside the brain’s default mode network.
Placebo effects are often misunderstood as “fake” responses, but neuroscience research has shown they involve measurable biological changes in the brain. In depression care, expectancy effects can influence how strongly patients respond to antidepressants, psychotherapy, or neuromodulation interventions. Researchers have increasingly focused on whether these expectancy pathways could be intentionally enhanced to improve treatment outcomes.
Why Theta Burst Stimulation Placebo Effects Matter In Depression
The new study examined whether transcranial magnetic stimulation targeting the dorsomedial prefrontal cortex could directly alter placebo-related brain activity. Researchers specifically focused on the default mode network, or DMN, which has been repeatedly linked to self-referential thinking, mood regulation, and antidepressant response.
The trial enrolled adults between ages 18 and 53 with depressive symptoms who were not taking psychotropic medications. Participants underwent three separate stimulation conditions spaced one week apart. These included intermittent theta burst stimulation, continuous theta burst stimulation, and a sham condition designed to imitate treatment without delivering active stimulation.
After each session, participants completed an antidepressant placebo functional MRI task that used expectancy cues and sham neurofeedback to manipulate beliefs about treatment effectiveness. Researchers then measured mood changes, expectancy ratings, and neural activation patterns.
How Brain Network Modulation Changed Mood Responses
One of the most important findings involved intermittent theta burst stimulation, commonly called iTBS. Researchers observed that iTBS increased dorsomedial prefrontal cortex activity within the default mode network compared with continuous theta burst stimulation.
More importantly, stronger DMN activation during iTBS predicted larger expectancy-related mood improvements. This suggests that neuromodulation may amplify the emotional impact of positive treatment expectations by reshaping activity in networks involved in mood processing.
Interestingly, continuous theta burst stimulation produced a different effect. While cTBS increased expectancy ratings themselves, it did not strengthen mood responses in the same way. Investigators suggested this may reflect engagement of upstream brain regions involved in cognitive appraisal rather than direct emotional modulation.
These contrasting outcomes highlight the complexity of brain stimulation protocols. Different stimulation patterns may influence separate components of the placebo response, including conscious expectancy formation and downstream emotional experience.
What Makes This Theta Burst Stimulation Study Different
The study stands out because it moves beyond observational correlations and attempts to establish causal evidence linking neuromodulation, expectancy processing, and mood improvement. Previous depression studies have shown associations between placebo responses and neural activity, but direct experimental manipulation has been limited.
Researchers also used a within-person counterbalanced design, allowing participants to serve as their own controls across different stimulation conditions. This approach reduces variability and strengthens confidence in the observed neural effects.
Another notable aspect is the focus on the dorsomedial prefrontal cortex rather than the more commonly targeted dorsolateral prefrontal cortex used in standard TMS depression protocols. The dorsomedial region has increasingly attracted attention for its role in emotional regulation, self-focused cognition, and large-scale network connectivity.
The findings may also support broader efforts to personalize neuromodulation strategies. Instead of treating TMS as a purely symptom-driven intervention, future protocols could potentially incorporate expectancy optimization and network-level targeting.
Could Expectancy Mechanisms Improve Future TMS Treatments
The clinical implications remain early but potentially significant. If certain stimulation patterns can strengthen adaptive expectancy pathways, clinicians may eventually combine neuromodulation with psychological interventions that reinforce positive treatment engagement.
This concept aligns with growing interest in precision psychiatry, where treatments are tailored not only to symptoms but also to underlying circuit dysfunctions and cognitive processes. Researchers increasingly recognize that depression involves disruptions across interconnected neural systems rather than isolated brain regions.
Importantly, the investigators did not suggest placebo responses should replace established therapies. Instead, the work highlights how expectancy mechanisms may represent one additional biological pathway contributing to treatment success.
Larger studies will still be needed to determine whether these findings translate into durable clinical improvements for patients with major depressive disorder. Researchers must also clarify how these network changes evolve over time and whether repeated stimulation sessions could strengthen the effects.
Still, the study adds to mounting evidence that brain stimulation may influence more than neuronal firing patterns alone. It may also shape how the brain interprets hope, anticipation, and emotional change during treatment itself.
Citations
- JAMA Psychiatry Study On Theta Burst Stimulation And Placebo Mood Effects
- PubMed Record For Intermittent Theta Burst Stimulation Of The Dorsomedial PFC And Expectancy-Driven Placebo Mood Effects
Explore more at https://www.interventionalpsychiatry.org/